1.
Akhuemokhan OC, Ewah-Odiase RO, Akpede N, et al. Prevalence of Lassa Virus Disease (LVD) in Nigerian children with fever or fever and convulsions in an endemic area. PLoS Negl Trop Dis. 2017;11(7):e0005711. doi:10.1371/journal.pntd.0005711.
1.
Siddle KJ, Eromon P, Barnes KG, et al. Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018. N Engl J Med. 2018;379(18):1745-1753. doi:10.1056/NEJMoa1804498.
1.
Boisen ML, Hartnett JN, Shaffer JG, et al. Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever. Sci Rep. 2018;8(1):5939. doi:10.1038/s41598-018-24246-w.
1.
Gire SK, Stremlau M, Andersen KG, et al. Epidemiology. Emerging disease or diagnosis?. Science. 2012;338(6108):750-2. doi:10.1126/science.1225893.
1.
Shaffer JG, Grant DS, Schieffelin JS, et al. Lassa fever in post-conflict sierra leone. PLoS Negl Trop Dis. 2014;8(3):e2748. doi:10.1371/journal.pntd.0002748.
1.
Andersen KG, Shapiro J, Matranga CB, et al. Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus. Cell. 2015;162(4):738-50. doi:10.1016/j.cell.2015.07.020.
1.
Matranga CB, Andersen KG, Winnicki S, et al. Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples. Genome Biol. 2014;15(11):519. doi:10.1186/PREACCEPT-1698056557139770.